Diagnostic test
K-RAS GENOTYPING TEST (PHARMACOGENOMICS) - (Outlab)
About test
What does K-RAS GENOTYPING TEST (PHARMACOGENOMICS) - (Outlab) measure?
This pharmacogenomic test checks for changes (mutations) in the K-RAS gene. K-RAS status may help healthcare professionals assess whether certain targeted cancer medicines are likely to be suitable, particularly in some solid tumours. It may also be used to support treatment planning and prognosis discussions alongside other clinical and pathology findings. Results should be interpreted in the individual’s clinical context.
This overview is educational. Use the recorded preparation, sample and lab-partner details below for collection guidance, and confirm any missing information before collection.
Choose a laboratory
Compare eligible lab partners
Prices, report times and availability are shown from the catalog records for each eligible partner.
Thyrocare
- Sample for analysis
- Confirm with the collection team
- Report time
- To be confirmed
Preparation and specimen requirements can vary by test and laboratory. Follow the instructions shown for your selected partner and any advice from your healthcare professional.